Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes

Publication ,  Conference
Yang, JY; Alexopoulos, A; Moon, AM; Kim, H; Pate, V; Barritt, AS; Sturmer, T; Buse, JB
Published in: Pharmacoepidemiology and Drug Safety
2020

Duke Scholars

Published In

Pharmacoepidemiology and Drug Safety

EISSN

1099-1557

ISSN

1053-8569

Publication Date

2020

Volume

29

Start / End Page

606 / 606

Related Subject Headings

  • Pharmacology & Pharmacy
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yang, J. Y., Alexopoulos, A., Moon, A. M., Kim, H., Pate, V., Barritt, A. S., … Buse, J. B. (2020). Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes. In Pharmacoepidemiology and Drug Safety (Vol. 29, pp. 606–606).
Yang, Jeff Y., Anastasia Alexopoulos, Andrew M. Moon, Hannah Kim, Virginia Pate, A Sidney Barritt, Til Sturmer, and John B. Buse. “Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes.” In Pharmacoepidemiology and Drug Safety, 29:606–606, 2020.
Yang JY, Alexopoulos A, Moon AM, Kim H, Pate V, Barritt AS, et al. Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes. In: Pharmacoepidemiology and Drug Safety. 2020. p. 606–606.
Yang, Jeff Y., et al. “Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes.” Pharmacoepidemiology and Drug Safety, vol. 29, 2020, pp. 606–606.
Yang JY, Alexopoulos A, Moon AM, Kim H, Pate V, Barritt AS, Sturmer T, Buse JB. Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes. Pharmacoepidemiology and Drug Safety. 2020. p. 606–606.

Published In

Pharmacoepidemiology and Drug Safety

EISSN

1099-1557

ISSN

1053-8569

Publication Date

2020

Volume

29

Start / End Page

606 / 606

Related Subject Headings

  • Pharmacology & Pharmacy
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences